---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-048040"
form_type: "8-K/A"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:26:07.261581+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BiomX files APT financials: net loss $16M, going concern doubt

## Summary
- APT net loss of $16.0M in 2023 and $23.6M in 2022; accumulated deficit $67.3M at Dec 31, 2023.
- APT revenue $14.1M in 2023 vs $5.9M in 2022 from government grants; cash only $1.3M.
- Auditor's report includes going concern emphasis; current cash insufficient for 12 months.
- APT issued $12.0M of Series B-1 preferred in 2023 but needs additional financing.
- Financials filed to complete previously reported acquisition of APT by BiomX.

## SEC filing metadata
- accession: 0001213900-24-048040
- form_type: 8-K/A
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390024048040/0001213900-24-048040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390024048040/ea0207019-8ka1_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-048040
- JSON: https://secwatch.observer/filing/0001213900-24-048040.json
- Plain text: https://secwatch.observer/filing/0001213900-24-048040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.